BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15660384)

  • 1. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
    Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
    Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.
    Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F
    J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo.
    Walter E; Keist R; Niederöst B; Pult I; Blum HE
    Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri.
    Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced intracellular retention of a hepatitis B virus strain associated with fulminant hepatitis.
    Inoue J; Ueno Y; Nagasaki F; Wakui Y; Kondo Y; Fukushima K; Niitsuma H; Shimosegawa T
    Virology; 2009 Dec; 395(2):202-9. PubMed ID: 19850315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
    Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
    Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
    Wu W; Chen Y; Ruan B; Li LJ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
    Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
    Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression.
    Du J; Liang X; Liu Y; Qu Z; Gao L; Han L; Liu S; Cui M; Shi Y; Zhang Z; Yu L; Cao L; Ma C; Zhang L; Chen Y; Sun W
    Cell Death Differ; 2009 Feb; 16(2):219-29. PubMed ID: 18927587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
    Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
    J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entry of hepatitis B virus: mechanism and new therapeutic target.
    Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
    Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes.
    von Weizsäcker F; Köck J; MacNelly S; Ren S; Blum HE; Nassal M
    Methods Mol Med; 2004; 96():153-61. PubMed ID: 14762267
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
    Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
    J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
    Fujiwara K; Tanaka Y; Paulon E; Orito E; Sugiyama M; Ito K; Ueda R; Mizokami M; Naoumov NV
    J Virol; 2005 Nov; 79(22):14404-10. PubMed ID: 16254374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.